Inari Medical Inc
NASDAQ:NARI

Watchlist Manager
Inari Medical Inc Logo
Inari Medical Inc
NASDAQ:NARI
Watchlist
Price: 49.66 USD -0.18% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Inari Medical Inc?
Write Note

Inari Medical Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Inari Medical Inc
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Inari Medical Inc
NASDAQ:NARI
Operating Expenses
-$438.2m
CAGR 3-Years
-59%
CAGR 5-Years
-97%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Operating Expenses
-$6.3B
CAGR 3-Years
1%
CAGR 5-Years
-1%
CAGR 10-Years
-9%
Boston Scientific Corp
NYSE:BSX
Operating Expenses
-$8.1B
CAGR 3-Years
-10%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
Stryker Corp
NYSE:SYK
Operating Expenses
-$9.2B
CAGR 3-Years
-8%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
Abbott Laboratories
NYSE:ABT
Operating Expenses
-$16B
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Expenses
-$3.2B
CAGR 3-Years
-17%
CAGR 5-Years
-14%
CAGR 10-Years
-14%
No Stocks Found

Inari Medical Inc
Glance View

Market Cap
2.9B USD
Industry
Health Care

Inari Medical, Inc. operates as a medical device company. The company is headquartered in Irvine, California and currently employs 800 full-time employees. The company went IPO on 2020-05-22. The firm operates through the development and commercialization of invasive mechanical thrombectomy devices to treat thromboembolism in the venous system. Its product offerings consist of two minimally invasive, catheter-based mechanical thrombectomy systems, which are for venous system and the treatment of the two distinct manifestations of venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism (PE). The Company’s products include ClotTriever System, FlowTriever System, FlowSaver, FlowStasis and FlowTriever 2. The ClotTriever system is a mechanical thrombectomy system designed to core, capture and remove large clots from large vessels and is used to treat DVT and its components include ClotTriever Catheter and ClotTriever Sheath. The FlowTriever is a large bore catheter-based aspiration and mechanical thrombectomy system designed to remove large clots from large vessels to treat PE.

NARI Intrinsic Value
33.36 USD
Overvaluation 33%
Intrinsic Value
Price

See Also

What is Inari Medical Inc's Operating Expenses?
Operating Expenses
-438.2m USD

Based on the financial report for Dec 31, 2023, Inari Medical Inc's Operating Expenses amounts to -438.2m USD.

What is Inari Medical Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-97%

Over the last year, the Operating Expenses growth was -19%. The average annual Operating Expenses growth rates for Inari Medical Inc have been -59% over the past three years , -97% over the past five years .

Back to Top